AI Science Tracker

Generate:Biomedicines

1 discovery from 2023

Discoveries

Chroma: a generative model for protein design

Generate:Biomedicines published the Chroma model in Nature; it designs new proteins with requested biophysical, biological and therapeutic properties. The weights are freely available to academic and nonprofit researchers. The press release gives no experimental figures, and performance claims come from the company.

Technology: Chroma (generative model)

Family Chroma: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The Nature paper reports experimental characterization of 310 designed proteins and crystal structures of two designs matching the predicted structures (backbone RMSD about 1.0 Å); the press release itself describes no experiments and states no limitations.
  • Still unknown: The paper abstract states no limitations; the press release gives no experimental figures and its performance claims come from the company.
  • AI role: A generative model samples protein structures and sequences and can be conditioned on specified properties or functions.

Evidence sources: https://generatebiomedicines.com/news-releases/generatebiomedicines-announces-publication-of-its-chroma-model-in-nature/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06728-8&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 585 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.